Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join the company as the vice president and US head of neurosciences, effective immediately. 15 August 2017
It seemed inevitable that change was on the horizon when Emma Walmsley’s appointment as chief executive of UK pharma major GlaxoSmithKline, taking over from Sir Andrew Witty, was announced nearly a year ago. 7 August 2017
Trying to control investor and media relations for Anglo-Swedish pharma major AstraZeneca remains an unenviable task, with leaks now appearing to suggest that chief executive Pascal Soriot is staying. 24 July 2017
The share price of Canada-based Aeterna Zentaris’ had shot up by nearly 200% to $3.01 by Friday lunchtime compared to Tuesday’s close, with the company considering what to do with new-found success. 21 July 2017
AstraZeneca’s chief executive Pascal Soriot is the leading candidate to be the CEO of Israel’s generics giant Teva Pharmaceutical Industries, according to Israeli newspapers Haaretz and Calcalist. 13 July 2017
As talks begin in earnest on the UK’s departure from the European Union, the trade group European Federation of Pharmaceutical Industries and Associations (EFPIA) expresses its concern that the Heads of State on Thursday decided to postpone a resolution on the relocation of the European Medicines Agency until November this year. 26 June 2017
Danish drugmaker LEO Pharma today announced that it appointed Chris Posner as executive vice president Region US and president and chief executive LEO Pharma Inc. 23 June 2017
US fertility treatment specialist OvaScience will cut its workforce and appoint a new chief executive, Christopher Kroeger, in a bid to slow the company’s cash burn rate and focus on key clinical development goals. 22 June 2017
In a battle which commentators might observe embodies a wider conflict of its time, the row engulfing Netherlands-incorporated drugmaker Mylan has entered another ugly round. 13 June 2017
Mylan is fighting battles on multiple fronts, including over price increases of its EpiPen (epinephrine) devices and as it races to market with its biosimilar products. 7 June 2017
Privately-held Swiss firm Ferring Pharmaceuticals today announced that Paul Navarre has been appointed chief executive of Ferring Holding Inc. 2 June 2017
Japan’s Astellas Pharma has promoted Shontelle Dodson to senior vice president and head of medical affairs Americas, effective May 15, 2017. Ms Dodson previously served as vice president of medical excellence within the global medical affairs organization. 12 May 2017
German family-owned drugmaker Grünenthal has appointed Mark Fladrich to the position of chief commercial officer (CCO) responsible for the firm’s entire global commercial organization. 9 May 2017
Bayer hA appointed Bhavesh Ashar as senior vice president and head of oncology for the company's Pharmaceuticals Division in the USA, reporting to Carsten Brunn, head of Bayer Pharmaceuticals for the Americas region. 3 May 2017
In the midst of a comprehensive cost cutting program rumored to include thousands of job losses, Teva chief financial officer Eyal Desheh is about to quit, Israeli press reports. 3 May 2017
Recently-floated PLx Pharma has made two new executive appointments, hiring Rita O’Connor as chief financial officer and Michael Dillon as vice president of sales and marketing. 3 May 2017
Sweden’s Karolinska Development says that Bo Jesper Hansen, chairman of the company's board, has decided not stand for re-election at the 2017 Annual General Meeting. 20 April 2017
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
Lykos Therapeutics has announced a reorganization to best support the company as it works to address the resubmission of its new drug application (NDA) for midomafetamine capsules for the treatment of post-traumatic stress disorder (PTSD) in adults. 16 August 2024
German infectious disease specialist AiCuris Anti-infective Cures has announced the appointment of Cynthia Wat as chief medical officer (CMO). 30 July 2024
Ophirex, a registered public benefit corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, has announced the appointment of Jeremy Gowler as chief executive. 15 July 2024
US drugmaker AbbVie has announced that Roopal Thakkar, who currently serves as senior vice president, chief medical officer, global therapeutics, has been appointed to the position of executive vice president, research and development, and chief scientific officer (CSO). 10 July 2024